1
|
Ono T, Itoh Y, Ishihara S, Kawamura M, Oie Y, Takase Y, Okumura M, Oyoshi H, Nagai N, Naganawa S. Optimized radiotherapy treatment strategy for early glottic carcinoma. Nagoya J Med Sci 2023; 85:241-254. [PMID: 37346844 PMCID: PMC10281837 DOI: 10.18999/nagjms.85.2.241] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/30/2022] [Accepted: 05/27/2022] [Indexed: 06/23/2023]
Abstract
The local control rates of T1 bulky and T2 glottic carcinoma treated via radiation therapy alone are unsatisfactory; thus, we aimed to evaluate the efficacy and safety of our treatment protocol for early glottic carcinoma. Patients with early glottic squamous cell carcinoma treated via radiation therapy from January 2007 to November 2019 were reviewed. Patients were treated with: 63-67.5 Gy/28-30 fractions of radiation therapy alone for T1 non-bulky; concurrent chemoradiotherapy with S-1 and 60 Gy/30 fractions for T1 bulky and T2 favorable; and concurrent chemoradiotherapy with high-dose cisplatin and 66-70 Gy/33-35 fractions for T2 unfavorable glottic carcinoma. Local failure rates were estimated using the cumulative incidence function, overall and disease specific survival rates were estimated using Kaplan-Meier analysis, and adverse events were evaluated. Eighty patients were analyzed; the median age was 69.5 (range, 26-90) years, the median follow-up time for survivors was 40.1 (range, 1.9-128.4) months, and the 3-year local failure, disease specific survival, and overall survival rates were 5.8%, 98.3%, and 94.4%, respectively. In T1 bulky and T2 cases, the local failure rate was significantly lower in the concurrent chemoradiotherapy than in the radiation therapy alone group. Grade 3 acute dermatitis and mucositis were noted in nine and four patients, respectively. There were no acute adverse events of Grade 4 or higher, or late adverse events of Grade 2 or higher. The treatment protocol was effective and well-tolerated; thus, the efficacy of concurrent chemoradiotherapy was suggested in T1 bulky and T2 cases.
Collapse
Affiliation(s)
- Tamami Ono
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Yoshiyuki Itoh
- Department of Radiology, Anjyo Kosei Hospital, Anjyo, Japan
| | - Shunichi Ishihara
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Mariko Kawamura
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Yumi Oie
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Yuuki Takase
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Masayuki Okumura
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Hidekazu Oyoshi
- Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan
| | - Naoya Nagai
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Shinji Naganawa
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| |
Collapse
|
2
|
Ito M, Yoshioka Y, Takase Y, Suzuki J, Takahashi H, Minami Y, Sakuragi A, Oshima Y, Okuda T, Suzuki K. Stereotactic body radiation therapy for prostate cancer: a study comparing 3-year genitourinary toxicity between CyberKnife and volumetric-modulated arc therapy by propensity score analysis. Radiat Oncol 2023; 18:39. [PMID: 36823674 PMCID: PMC9948419 DOI: 10.1186/s13014-023-02233-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2022] [Accepted: 02/20/2023] [Indexed: 02/25/2023] Open
Abstract
BACKGROUND To investigate whether the rate of stereotactic body radiation therapy-related (SBRT-related) genitourinary (GU) toxicity is lower in patients with prostate cancer treated with CyberKnife. METHODS We retrospectively reviewed the medical records of patients with nonmetastatic prostate cancer at two institutions between 2017 and 2020. We analyzed 70 patients who were extracted by propensity score matching based on age, pre-treatment International Prostate Symptom Score (IPSS), and prostate volume. The patients were treated with SBRT, with a total dose of 36.25 Gy in five fractions over five consecutive weekdays, using CyberKnife or volumetric-modulated arc therapy (VMAT). RESULTS The low-, medium-, and high-risk patients were 2, 19, and 14, respectively, in the CyberKnife group and 4, 17, and 14, respectively, in the VMAT group. The median follow-up time in both groups was 3 years. One patient with CyberKnife died of unrelated causes. No biochemical or clinical recurrence, distant metastases, or death from prostate cancer was observed. The peak values of IPSS in the acute phase (< 3 months) were significantly lower in the CyberKnife than in the VMAT group (CyberKnife:16.2 vs VMAT:20.2, p = 0.025). In multiple regression analyses, the treatment modality (p = 0.03), age (p = 0.01), bladder medication pre-irradiation (p = 0.03), and neoadjuvant androgen deprivation therapy (p = 0.04) contributed to the peak value of the acute-phase IPSS. The incidence of treatment-related grade 2 acute GU toxicity tended to be lower in the CyberKnife than the VMAT group (CyberKnife: 22.9% vs. VMAT: 45.7%, p = 0.077). No difference was noted between the groups with regard to late IPSS or GU toxicity and gastrointestinal toxicity in all phases. Toxicities of grade ≥ 3 have not been observed to date. CONCLUSIONS Regardless of treatment modality, SBRT is effective in treating prostate cancer without serious toxicity. However, CyberKnife has an advantage over VMAT in terms of acute prostate symptoms.
Collapse
Affiliation(s)
- Makoto Ito
- Department of Radiology, Aichi Medical University Hospital, 1-1 Yazako-Karimata, Nagakute, Aichi, 480-1195, Japan.
| | - Yasuo Yoshioka
- grid.410807.a0000 0001 0037 4131Department of Radiation Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-Ku, Tokyo, 135-8550 Japan ,grid.417248.c0000 0004 1764 0768Department of Radiation Oncology, Toyota Memorial Hospital, 1-1-1 Heiwa-Cho, Toyota, Aichi 471-8513 Japan
| | - Yuuki Takase
- grid.437848.40000 0004 0569 8970Department of Radiology, Nagoya University Hospital, 65 Tsurumai-Cho, Showa-Ku, Nagoya, Aichi 466-8560 Japan
| | - Junji Suzuki
- grid.417248.c0000 0004 1764 0768Department of Radiotherapy Quality Management Group, Toyota Memorial Hospital, 1-1-1 Heiwa-Cho, Toyota, Aichi 471-8513 Japan
| | - Hironori Takahashi
- grid.417248.c0000 0004 1764 0768Department of Radiation Oncology, Toyota Memorial Hospital, 1-1-1 Heiwa-Cho, Toyota, Aichi 471-8513 Japan
| | - Yoshitaka Minami
- grid.510308.f0000 0004 1771 3656Department of Central Radiology, Aichi Medical University Hospital, 1-1 Yazako-Karimata, Nagakute, Aichi 480-1195 Japan
| | - Ami Sakuragi
- grid.510308.f0000 0004 1771 3656Department of Central Radiology, Aichi Medical University Hospital, 1-1 Yazako-Karimata, Nagakute, Aichi 480-1195 Japan
| | - Yukihiko Oshima
- grid.510308.f0000 0004 1771 3656Department of Radiology, Aichi Medical University Hospital, 1-1 Yazako-Karimata, Nagakute, Aichi 480-1195 Japan
| | - Takahito Okuda
- grid.417248.c0000 0004 1764 0768Department of Radiation Oncology, Toyota Memorial Hospital, 1-1-1 Heiwa-Cho, Toyota, Aichi 471-8513 Japan
| | - Kojiro Suzuki
- grid.510308.f0000 0004 1771 3656Department of Radiology, Aichi Medical University Hospital, 1-1 Yazako-Karimata, Nagakute, Aichi 480-1195 Japan
| |
Collapse
|
3
|
Nakakubo Y, Tsuji H, Takase Y, Iwasaki T, Shirakashi M, Onizawa H, Hiwa R, Kitagori K, Akizuki S, Nakashima R, Onishi A, Yoshifuji H, Tanaka M, Morinobu A. AB0470 THE ASSOCIATIONS OF ANTI-DNA ANTIBODIES WITH DISEASE ACTIVITY INDICES AND PATIENT REPORT OUTCOME PARAMETERS OF SLE IN KYOTO LUPUS COHORT. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.1304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BackgroundSince the goals of remission or low disease activity are becoming more realistic with advances in treatment for SLE, there is a need to examine the measurements for SLE especially in patients with low disease activity. It has been known that disease activities in SLE are correlated with anti-DNA antibodies (Abs). However, it was not clear which measurements of disease activities or patient reported outcomes correlate better with anti-DNA Abs.ObjectivesTo examine the association between parameters for SLE and anti-DNA Abs measured with RIA in Kyoto Lupus Cohort, a SLE registry in Kyoto University Hospital from 2019 to 2021.Methods1)Correlations between anti-DNA Abs with SLEDAI, M-SLEDAI (SLEDAI without anti-DNA Abs), VAS, LupusPRO, SF-36, and Systemic lupus erythematosus Symptom Checklist (SSC) were evaluated cross-sectionally (n = 310).2)The alterations in SLE parameters and anti-DNA Abs between two visits were examined (n = 106). Further, the correlations within 3 months were examined in cases with flare-ups of SLE (the alteration in SLEDAI > 0 and anti-DNA Abs≧0, n = 39). The associations of the alterations of anti-DNA Abs with each item of SLEDAI classified by organs were also examined.Results1)31 percent of the cases in the entire registry was classified as remission or low disease activity (Table 1). SLEDAI (mean±SD) was higher in patients positive for anti-DNA Abs (7.94±5.20) than that in patients negative for anti-DNA Abs (4.56±4.65) (p < 0.0001). Anti-DNA Abs were weakly correlated with SLEDAI (R = 0.24 [p < 0.0001]), M-SLEDAI (R = 0.15 [p = 0.014]), and Physician-VAS (R = 0.19 [p = 0.0016]). On the other hand, there were no significant correlations between anti-DNA Abs and LupusPRO and SSC. Some dimensions in SF-36 had weak correlations with anti-DNA Abs, while no component summary scores had significant correlations with anti-DNA Abs.Table 1.Patients’ demographics and disease characteristics in the cohort (n = 310).VariableResultsAge (years)47.7 (39.4, 57.5)Female sexn = 284 (91.6%)Disease duration (years)15.9 (9.4, 24.5)Anti-DNA Ab positivity†n = 106 (34.2%)Anti- DNA Ab titer (U/mL)4 (0, 8)SLEDAI4 (2, 8)SLEDAI<=4n = 162 (52.1%)SSC31 (16.2, 52.5)Remission or LDAn = 95 (30.7%)Patient-VAS38 (15, 52)Physician-VAS13.3 (3.3, 23.3)SF-36 PCS45.4 (36.6, 52.4)SF-36 MCS48.2 (41.5, 53.6)SF-36 RCS51.3 (42.6, 58.6)LupusPRO HQOL70.2 (54.8, 86.5)LupusPRO NHQOL41.7 (31.3, 51.0)Glucocorticoid (mg/day)5 (4, 8)* Data are n (%) or median (Q1, Q3).† Anti-DNA Ab positivity at the time of the cross-sectional observation.2)No significant correlations were observed between the alterations of SLEDAI and anti-DNA Abs (R = 0.00 [95% CI: -0.23 – 0.22, p = 0.95]) in the total of patients with various range of observation periods (Figure 1A). In contrast, a significant correlation was observed (R = 0.32, p = 0.04) within 3 months after the flare-ups of SLE (Figure 1B). No significant correlations were found between the alterations in VAS and anti-DNA Abs, or the alterations of SSC and anti-DNA Abs. They showed the following organ symptoms: renal involvement, 62.8%; musculoskeletal, 17.1%; neuropsychiatric, 11.4%; hematological, 5.7%; mucocutaneous, 11.4%; serositis, 2.9%, and fever, 2.9%.Figure 1.The associations between the alteration in anti-DNA Ab and SLEDAIConclusionThe associations between anti-DNA Abs with several parameters of SLE were examined. Anti-DNA Abs correlated with disease activities (SLEDAI) in SLE patients, especially when observed in the condition of flare-up.References[1]Ho A, et al. Arthritis Rheum. 2001;44:2342-9.Disclosure of InterestsNone declared
Collapse
|
4
|
Watanabe O, Ko Y, Tsujii N, Takase Y, Ejiri A, Shinohara K, Peng Y, Iwasaki K, Yamada I, Yatomi G, Moeller C, Peng YK. Design of a finline antenna for current drive in TST-2. Fusion Engineering and Design 2022. [DOI: 10.1016/j.fusengdes.2022.113094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
5
|
Oie Y, Itoh Y, Kawamura M, Takase Y, Murao T, Ishihara S, Nomoto Y, Hirasawa N, Asano A, Yamakawa K, Ito J, Kinoshita F, Naganawa S. Poor local control of ulcerative T1 glottic cancer treated with 2.25-Gy per fraction radiotherapy. Nagoya J Med Sci 2021; 83:811-825. [PMID: 34916724 PMCID: PMC8648532 DOI: 10.18999/nagjms.83.4.811] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/09/2021] [Accepted: 05/07/2021] [Indexed: 11/30/2022]
Abstract
The Tokai Study Group for Therapeutic Radiology and Oncology (TOSTRO) started managing T1 glottic cancer using 2.25 Gy/fraction radiotherapy in 2011. The aim was to evaluate the local control (LC) rate and toxicity with 2.25-Gy radiotherapy in clinical practice and identify prognostic factors.The eligibility criteria were T1 glottic squamous cell carcinoma patients with age ≥20 years, treated with 2.25 Gy/fraction without chemotherapy between 2011 and 2017. LC rates were evaluated based on age, performance status, sex, T-category, tumor type (ulcerative or non-ulcerative), presence of anterior commissure invasion, tumor size, X-ray beam energy, and overall treatment time. Acute and late adverse events were evaluated using CTCAE version 4.0. A total of 202 patients were enrolled. The median follow-up period was 34.2 months. The 2- and 4-year LC rates were 93.8% and 93.1%, respectively. There was a significant difference in the LC rate between non-ulcerative type and ulcerative type (95.2% vs. 74.1% at 2 years, 94.4% vs. 74.1% at 4 years; p = 0.01). On univariate analysis, only tumor type was significantly correlated with a poor LC rate (hazard ratio 4.3; 95% confidence interval 1.2-15.4; p = 0.03). Acute grade 3 adverse events occurred in 17 patients. However, no late adverse events of grade 3 or higher have occurred to date. T1 glottic cancer treatment outcomes using hypofractionated radiotherapy with 2.25 Gy/fraction in clinical practice were comparable to previously reported results. However, ulcerative type tumor was associated with a poor LC rate.
Collapse
Affiliation(s)
- Yumi Oie
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
,Department of Radiology, Chubu Rosai Hospital, Nagoya, Japan
| | - Yoshiyuki Itoh
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
,Department of Radiology, Nishio Municipal Hospital, Nishio, Japan
| | - Mariko Kawamura
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Yuuki Takase
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
,Department of Radiation Oncology, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, Japan
| | - Takayuki Murao
- Department of Radiation Oncology, Ichinomiya Municipal Hospital, Ichinomiya, Japan
| | - Shunichi Ishihara
- Department of Radiology, Toyohashi Municipal Hospital, Toyohashi, Japan
| | - Yoshihito Nomoto
- Department of Radiology, Mie University Graduate School of Medicine, Tsu, Japan
| | - Naoki Hirasawa
- Department of Radiology, Komaki City Hospital, Komaki, Japan
| | - Akiko Asano
- Department of Radiation Oncology, Gifu Prefectural Tajimi Hospital, Tajimi, Japan
| | - Kouji Yamakawa
- Department of Radiology, Tosei General Hospital, Seto, Japan
| | - Junji Ito
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
,Department of Radiation Oncology, Nakatsugawa Municipal General Hospital, Nakatsugawa, Japan
| | - Fumie Kinoshita
- Statistical Analysis Section, Data Coordinating Center, Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan
| | - Shinji Naganawa
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| |
Collapse
|
6
|
Kawamura M, Koide Y, Murai T, Ishihara S, Takase Y, Murao T, Okazaki D, Yamaguchi T, Uchiyama K, Itoh Y, Kodaira T, Shibamoto Y, Mizuno M, Kikkawa F, Naganawa S. The importance of choosing the right strategy to treat small cell carcinoma of the cervix: a comparative analysis of treatments. BMC Cancer 2021; 21:1046. [PMID: 34556082 PMCID: PMC8461987 DOI: 10.1186/s12885-021-08772-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2020] [Accepted: 09/08/2021] [Indexed: 12/03/2022] Open
Abstract
Background Standard treatments for small cell carcinoma of the cervix (SCCC) have not been established. In this study, we aimed to estimate the optimal treatment strategy for SCCC. Methods This was a multicenter retrospective study. Medical records of patients with pathologically proven SCCC treated between 2003 and 2016 were retrospectively analyzed. Overall survival (OS) was plotted using the Kaplan-Meier method. Log-rank tests and Cox regression analysis were used to assess the differences in survival according to stage, treatment strategy, and chemotherapy regimen. Results Data of 78 patients were collected, and after excluding patients without immunohistopathological staining, 65 patients were evaluated. The median age of the included patients was 47 (range: 24–83) years. The numbers of patients with International Federation of Gynecology and Obstetrics (FIGO) 2018 stages I-IIA, IIB-IVA, IVB were 23 (35%), 34 (52%), and 8 (12%), respectively. Of 53 patients who had undergone chemotherapy, 35 and 18 received SCCC and non-SCCC regimens as their first-line chemotherapy regimen, respectively. The 5-year OS for all patients was 49%, while for patients with FIGO stages I-IIA, IIB-IVA, IVB, it was 60, 50, and 0%, respectively. The 5-year OS rates for patients who underwent treatment with SCCC versus non-SCCC regimens were 59 and 13% (p < 0.01), respectively. This trend was pronounced in locally advanced stages. Multivariate analysis showed that FIGO IVB at initial diagnosis was a significant prognostic factor in all patients. Among the 53 patients who received chemotherapy, the SCCC regimen was associated with significantly better 5-year OS in both the uni- and multivariate analyses. Conclusion Our results suggest that the application of an SCCC regimen such as EP or IP as first-line chemotherapy for patients with locally advanced SCCC may play a key role in OS. These findings need to be validated in future nationwide, prospective clinical studies. Supplementary Information The online version contains supplementary material available at 10.1186/s12885-021-08772-x.
Collapse
Affiliation(s)
- Mariko Kawamura
- Department of Radiology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Shouwa-ku, Nagoya, Aichi, 466-8550, Japan.
| | - Yutaro Koide
- Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Japan
| | - Taro Murai
- Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
| | - Shunichi Ishihara
- Department of Radiology, Toyohashi Municipal hospital, Toyohashi, Japan
| | - Yuuki Takase
- Department of Radiology, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, Japan
| | - Takayuki Murao
- Department of Radiology, Ichinomiya Municipal Hospital, Ichinomiya, Japan
| | - Dai Okazaki
- Department of Radiology, Okazaki City Hospital, Okazaki, Japan
| | | | - Kaoru Uchiyama
- Department of Radiology, Kariya-Toyota General Hospital, Kariya, Japan
| | - Yoshiyuki Itoh
- Department of Radiology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Shouwa-ku, Nagoya, Aichi, 466-8550, Japan
| | - Takeshi Kodaira
- Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Japan
| | - Yuta Shibamoto
- Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
| | - Mika Mizuno
- Department of Obstetrics and Gynecology, Aichi Cancer Center Hospital, Nagoya, Japan
| | - Fumitaka Kikkawa
- Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Shinji Naganawa
- Department of Radiology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Shouwa-ku, Nagoya, Aichi, 466-8550, Japan
| |
Collapse
|
7
|
Takase Y, Kawamura M, Nakahara R, Itoh J, Oie Y, Okumura M, Kamomae T, Itoh Y, Ono T, Naganawa S. PO-1036 Malignant. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07487-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
8
|
Kawamura M, Nakahara R, Ishihara S, Oie Y, Takase Y, Okumura M, Ito J, Ono T, Itoh Y, Naganawa S. PO-1291 Can we safely lower the RT dose with the use of high dose PF for advanced cervical cancer? Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07742-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
9
|
Delgado-Aparicio LF, VanMeter P, Barbui T, Chellai O, Wallace J, Yamazaki H, Kojima S, Almagari AF, Hurst NC, Chapman BE, McCollam KJ, Den Hartog DJ, Sarff JS, Reusch LM, Pablant N, Hill K, Bitter M, Ono M, Stratton B, Takase Y, Luethi B, Rissi M, Donath T, Hofer P, Pilet N. Multi-energy reconstructions, central electron temperature measurements, and early detection of the birth and growth of runaway electrons using a versatile soft x-ray pinhole camera at MST. Rev Sci Instrum 2021; 92:073502. [PMID: 34340413 DOI: 10.1063/5.0043672] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/10/2021] [Accepted: 04/26/2021] [Indexed: 06/13/2023]
Abstract
A multi-energy soft x-ray pinhole camera has been designed, built, and deployed at the Madison Symmetric Torus to aid the study of particle and thermal transport, as well as MHD stability physics. This novel imaging diagnostic technique employs a pixelated x-ray detector in which the lower energy threshold for photon detection can be adjusted independently on each pixel. The detector of choice is a PILATUS3 100 K with a 450 μm thick silicon sensor and nearly 100 000 pixels sensitive to photon energies between 1.6 and 30 keV. An ensemble of cubic spline smoothing functions has been applied to the line-integrated data for each time-frame and energy-range, obtaining a reduced standard-deviation when compared to that dominated by photon-noise. The multi-energy local emissivity profiles are obtained from a 1D matrix-based Abel-inversion procedure. Central values of Te can be obtained by modeling the slope of the continuum radiation from ratios of the inverted radial emissivity profiles over multiple energy ranges with no a priori assumptions of plasma profiles, magnetic field reconstruction constraints, high-density limitations, or need of shot-to-shot reproducibility. In tokamak plasmas, a novel application has recently been tested for early detection, 1D imaging, and study of the birth, exponential growth, and saturation of runaway electrons at energies comparable to 100 × Te,0; thus, early results are also presented.
Collapse
Affiliation(s)
| | - P VanMeter
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - T Barbui
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - O Chellai
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - J Wallace
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - H Yamazaki
- National Institutes for Quantum and Radiological Science and Technology, Naka, Ibaraki 311-0193, Japan
| | - S Kojima
- Kyushu University, Kasuga-kouen 6-1, Kasuga, Japan
| | - A F Almagari
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - N C Hurst
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - B E Chapman
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - K J McCollam
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - D J Den Hartog
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - J S Sarff
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - L M Reusch
- Edgewood College, Madison, Wisconsin 53711, USA
| | - N Pablant
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - K Hill
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - M Bitter
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - M Ono
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - B Stratton
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - Y Takase
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - B Luethi
- DECTRIS Ltd., 5405 Baden-Dättwil, Switzerland
| | - M Rissi
- DECTRIS Ltd., 5405 Baden-Dättwil, Switzerland
| | - T Donath
- DECTRIS Ltd., 5405 Baden-Dättwil, Switzerland
| | - P Hofer
- DECTRIS Ltd., 5405 Baden-Dättwil, Switzerland
| | - N Pilet
- DECTRIS Ltd., 5405 Baden-Dättwil, Switzerland
| |
Collapse
|
10
|
Ito M, Yoshioka Y, Takase Y, Suzuki J, Matsunaga T, Takahashi H, Takeuchi A, Adachi S, Abe S, Oshima Y, Ohtakara K, Suzuki K, Okuda T. Stereotactic body radiation therapy for Japanese patients with localized prostate cancer: 2-year results and predictive factors for acute genitourinary toxicities. Jpn J Clin Oncol 2021; 51:1253-1260. [PMID: 34128053 DOI: 10.1093/jjco/hyab094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2021] [Accepted: 05/28/2021] [Indexed: 11/14/2022] Open
Abstract
OBJECTIVE We aimed to report the 2-year results of stereotactic body radiation therapy for prostate cancer and identify the clinical and dosimetric factors that predict acute genitourinary toxicities. METHODS We retrospectively reviewed the medical records of patients with non-metastatic prostate cancer treated at Toyota Memorial Hospital between 2017 and 2020. The patients were treated with stereotactic body radiation therapy with a total dose of 36.25 Gy in five fractions on consecutive weekdays. While low-risk patients received radiotherapy alone, intermediate- to high-risk patients also received androgen deprivation therapy. RESULTS We analysed a total of 104 patients, including 10, 60 and 34 low-, intermediate- and high-risk patients, respectively. The median follow-up duration was 2 years. We did not observe biochemical/clinical recurrence, distant metastasis or death from prostate cancer. One patient died of another cause. Grade 2 acute genitourinary toxicity was observed in 40 (38%) patients. Age (P = 0.021), genitourinary toxicity of grade ≥1 at baseline (P = 0.023) and bladder mean dose (P = 0.047) were significantly associated with the incidence of grade 2 acute genitourinary toxicity. The cut-off value of 65 years for age and 10.3 Gy for the bladder mean dose were considered the most appropriate. Grade 2 acute gastrointestinal toxicity was observed in five (5%) patients. None of the patients experienced grade ≥3 acute or late toxicity. CONCLUSIONS Stereotactic body radiation therapy is feasible for Japanese patients with prostate cancer, with acceptable acute toxicity. Age, genitourinary toxicity at baseline and bladder mean dose predict grade 2 acute genitourinary toxicity.
Collapse
Affiliation(s)
- Makoto Ito
- Department of Radiology, Aichi Medical University Hospital, Nagakute, Japan
| | - Yasuo Yoshioka
- Radiation Oncology Department, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto, Japan.,Department of Radiation Oncology, Toyota Memorial Hospital, Toyota, Japan
| | - Yuuki Takase
- Department of Radiology, Nagoya University Hospital, Nagoya, Japan
| | - Junji Suzuki
- Department of Radiation Oncology, Toyota Memorial Hospital, Toyota, Japan
| | - Takuma Matsunaga
- Department of Radiation Oncology, Toyota Memorial Hospital, Toyota, Japan
| | - Hironori Takahashi
- Department of Radiation Oncology, Toyota Memorial Hospital, Toyota, Japan
| | - Arisa Takeuchi
- Department of Radiation Oncology, Anjo Kosei Hospital Aichi Prefectural Welfare Federation of Agricultural Cooperatives, Anjo, Japan
| | - Sou Adachi
- Department of Radiology, Aichi Medical University Hospital, Nagakute, Japan
| | - Souichirou Abe
- Department of Radiology, Aichi Medical University Hospital, Nagakute, Japan
| | - Yukihiko Oshima
- Department of Radiology, Aichi Medical University Hospital, Nagakute, Japan
| | - Kazuhiro Ohtakara
- Department of Radiation Oncology, Kainan Hospital Aichi Prefectural Welfare Federation of Agricultural Cooperatives, Yatomi, Japan
| | - Kojiro Suzuki
- Department of Radiology, Aichi Medical University Hospital, Nagakute, Japan
| | - Takahito Okuda
- Department of Radiation Oncology, Toyota Memorial Hospital, Toyota, Japan
| |
Collapse
|
11
|
Hanada K, Yoshida N, Hasegawa M, Oya M, Oya Y, Takagi I, Hatayama A, Shikama T, Idei H, Nagashima Y, Ikezoe R, Onchi T, Kuroda K, Kawasaki S, Higashijima A, Nagata T, Shimabukuro S, Nakamura K, Murakami S, Takase Y, Gao X, Liu H, Qian J. Overview of recent progress on steady state operation of all-metal plasma facing wall device QUEST. Nuclear Materials and Energy 2021. [DOI: 10.1016/j.nme.2021.101013] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
12
|
Ito M, Sasamura K, Takase Y, Kotsuma T, Oshima Y, Minami Y, Suzuki J, Tanaka E, Ohashi W, Oguchi M, Okuda T, Suzuki K, Yoshioka Y. Comparison of Physician-recorded Toxicities and Patient-reported Outcomes of Five Different Radiotherapy Methods for Prostate Cancer. Anticancer Res 2021; 41:2523-2531. [PMID: 33952480 DOI: 10.21873/anticanres.15030] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2021] [Revised: 04/11/2021] [Accepted: 04/12/2021] [Indexed: 11/10/2022]
Abstract
BACKGROUND/AIM To compare five radiotherapy methods for prostate cancer. PATIENTS AND METHODS During 2005-2018, the data of patients with non-metastatic prostate cancer were retrospectively analysed. Patients were treated with high-dose-rate brachytherapy (HDR-BT); low-dose-rate brachytherapy (LDR-BT); or external-beam radiotherapy (EBRT), including conventionally fractionated radiotherapy (CFRT), moderate-hypofractionated radiotherapy (MHRT), and ultra-hypofractionated radiotherapy (UHRT). RESULTS In total, 496 patients (149, HDR-BT; 100, LDR-BT; 100, CFRT; 97, MHRT, and 50, UHRT) with a median follow-up of 4.3 years were enrolled. The incidence of grade ≥2 acute genitourinary toxicities was significantly lower with HDR-BT (p<0.001) than with any other radiotherapy. The cumulative incidence of late grade ≥2 genitourinary toxicities was the highest with UHRT and significantly higher (p=0.005) with UHRT than with HDR-BT. Higher symptom score peaks were noted 4 weeks after therapy for LDR-BT than for EBRT. CONCLUSION Physician-recorded toxicities were slightly lower with HDR-BT and patient-reported outcomes tended to be worse with LDR-BT.
Collapse
Affiliation(s)
- Makoto Ito
- Department of Radiology, Aichi Medical University Hospital, Nagakute, Japan; .,Department of Radiation Oncology, Toyota Memorial Hospital, Toyota, Japan
| | - Kazuma Sasamura
- Radiation Oncology Department, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan
| | - Yuuki Takase
- Department of Radiation Oncology, Toyota Memorial Hospital, Toyota, Japan.,Department of Radiology, Nagoya University Hospital, Nagoya, Japan
| | - Tadayuki Kotsuma
- Department of Radiation Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan.,Department of Radiology, Kaizuka City Hospital, Kaizuka, Japan
| | - Yukihiko Oshima
- Department of Radiology, Aichi Medical University Hospital, Nagakute, Japan
| | - Yoshitaka Minami
- Department of Radiology, Aichi Medical University Hospital, Nagakute, Japan
| | - Junji Suzuki
- Department of Radiation Oncology, Toyota Memorial Hospital, Toyota, Japan
| | - Eiichi Tanaka
- Department of Radiation Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan
| | - Wataru Ohashi
- Department of Biostatistics, Clinical Research Center, Aichi Medical University Hospital, Nagakute, Japan
| | - Masahiko Oguchi
- Radiation Oncology Department, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan
| | - Takahito Okuda
- Department of Radiation Oncology, Toyota Memorial Hospital, Toyota, Japan
| | - Kojiro Suzuki
- Department of Radiology, Aichi Medical University Hospital, Nagakute, Japan
| | - Yasuo Yoshioka
- Department of Radiation Oncology, Toyota Memorial Hospital, Toyota, Japan.,Radiation Oncology Department, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan
| |
Collapse
|
13
|
Ito M, Takase Y, Sasamura K, Kotsuma T, Ooshima Y, Minami Y, Suzuki J, Tanaka E, Oguchi M, Okuda T, Suzuki K, Yoshioka Y. Comparison of Physician-Recorded Toxicities and Patient-Reported Outcomes Among 5 Different Radiotherapy Methods for Prostate Cancer. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.543] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
14
|
Takase Y, Doi H, Iwasaki T, Hashimoto M, Inaba R, Kozuki T, Taniguchi M, Tabuchi Y, Kitagori K, Akizuki S, Murakami K, Nakashima R, Yoshifuji H, Yamamoto W, Tanaka M, Ohmura K. THU0285 ANALYSIS OF THE RELATIONSHIP BETWEEN ORGAN DAMAGE AND QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.3027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:Systemic lupus erythematosus (SLE) is an autoimmune disease that can not only cause systemic symptoms, such as fever and arthritis, but can also damage important organs, such as those of the central nervous system and the kidneys. Prevention of irreversible organ damage is important for better prognosis [1]. Additionally, the importance of maintaining the quality of life (QOL) of patients has recently been emphasized. However, only a few studies have examined the relationship between irreversible organ damage and patient QOL.Objectives:To assess the relationship between organ damage and QOL, and to survey which organs have more significant effects on QOL.Methods:We conducted a questionnaire-based survey of 183 patients with SLE at Kyoto University Hospital from September to December 2019. We used the SLICC/ACR Damage Index (SDI) to evaluate organ damage [2]. The following five scales were employed to evaluate QOL: the physical (PCS) and mental component summary (MCS) of the Medical Outcome Study (MOS) 36-Item Short-Form Health Survey version 2.0 (SF-36v2) [3], health (HRQOL) and non-health-related QOL (N-HRQOL) of LupusPRO [4], and SLE Symptom Checklist (SSC) [5].Results:Linear regression analysis showed significant correlation between the SDI score and all QOL scales except for N-HRQOL, suggesting negative effects of organ damage on QOL (Table 1). Next, we analysed whether there was a significant difference in the SF-36 score between those who were positive and negative for each SDI item (41 in total), using the Wilcoxon rank sum test. Muscle atrophy or weakness (p= 3.0×10-10), osteoporosis with fracture or vertebral collapse (p= 9.7×10-8), claudication (p= 7.4×10-5), and cognitive impairment or major psychosis (p= 9.9×10-5) significantly correlated (p< 1.2×10-3) with PCS, and scarring chronic alopecia (p= 3.4×10-4) with MCS (Table 2). In addition, the five SDI items significantly correlated with the remaining three QOL scales (HRQOL, N-HRQOL, and SSC;p< 0.05).Table 1.Relationship between the SDI score and QOLSF-36LupusPROSSCPCSMCSHRQOLN-HRQOLp-value<2.0×10-161.7×10-32.2×10-110.231.9×10-8Table 2.Relationship between each SDI item and the SF-36 score (p< 1.2×10-3SDI itemPCS scorep-valuePositive(Median (IQR))Negative(Median (IQR))Muscle atrophy/weakness33 (19-45)50 (43-54)3.0×10-10Osteoporosis with fracture/vertebral collapse24 (12-32)49 (38-54)9.7×10-8Claudication31 (19-35)49 (38-54)7.4×10-5Cognitive impairment/psychosis27 (17-33)49 (38-54)9.9×10-5SDI itemMCS scorep-valuePositive(Median (IQR))Negative(Median (IQR))Scarring chronic alopecia42 (29-51)49 (39-54)3.4×10-4Conclusion:We demonstrated that organ damage has negative effects on patient QOL, indicating the importance of preventing irreversible organ damage for maintaining QOL. Moreover, muscle atrophy/weakness, osteoporosis with fracture/vertebral collapse, claudication, cognitive impairment/major psychosis, and scarring chronic alopecia significantly correlated with QOL deterioration, suggesting that these items should be examined with special care in clinical practice.References:[1]Lopez R, et al. Rheumatology (Oxford). 2012; 51:491-498.[2]Gladman D, et al. Arthritis Rheum. 1996; 39:363-369.[3]Fukuhara S, et al. J Clin Epidemiol. 1998; 51:1037-1044.[4]Inoue M, et al. Lupus. 2017; 26:849-856.[5]Grootscholten C, et al. Qual Life Res. 2003; 12:635–644.Disclosure of Interests:Yudai Takase: None declared, Hiroshi Doi: None declared, Takeshi Iwasaki: None declared, Motomu Hashimoto Grant/research support from: Bristol-Myers Squibb, Eisai, and Eli Lilly and Company., Speakers bureau: Bristol-Myers Squibb and Mitsubishi Tanabe Pharma., Ryuta Inaba: None declared, Tomohiro Kozuki: None declared, Masashi Taniguchi: None declared, Yuya Tabuchi Paid instructor for: Astellas Pharma, GlaxoSmithKline, Mitsubishi Tanabe Pharma, and Nippon Shinyaku., Speakers bureau: AbbVie, Janssen Pharmaceutical, Mitsubishi Tanabe Pharma, Nippon Shinyaku, and Novartis Pharma. (Outside the field of the present study.), Koji Kitagori: None declared, Syuji Akizuki: None declared, Kosaku Murakami Speakers bureau: AbbVie, Eisai, and Mitsubishi Tanabe Pharma., Ran Nakashima Grant/research support from: Takeda Pharmaceutical. (Outside the field of the present study.), Speakers bureau: Astellas Pharma, Medical & Biological Laboratories, AstraZeneca, and Boehringer Ingelheim. (Outside the field of the present study.), Hajime Yoshifuji Grant/research support from: Astellas Pharma. (Outside the field of the present study.), Speakers bureau: Chugai Pharmaceutical. (Outside the field of the present study.), Wataru Yamamoto: None declared, Masao Tanaka Grant/research support from: AbbVie, Asahi Kasei Pharma, Astellas Pharma, Ayumi Pharmaceutical, Chugai Pharmaceutical, Eisai, Mitsubishi Tanabe Pharma, Taisho Pharmaceutical, and UCB Japan., Speakers bureau: AbbVie, Asahi Kasei Pharma, Astellas Pharma, Bristol-Myers Squibb, Chugai Pharmaceutical, Eisai, Eli Lilly and Company, Janssen Pharmaceutical, Mitsubishi Tanabe Pharma, Novartis Pharma, Pfizer, Taisho Pharmaceutical, Takeda Pharmaceutical, and UCB Japan., Koichiro Ohmura Grant/research support from: Astellas Pharma, AYUMI Pharmaceutical, Chugai Pharmaceutical, Daiichi Sankyo, Eisai, Japan Blood Products Organization, Mitsubishi Tanabe Pharma, Nippon Kayaku, Nippon Shinyaku, Sanofi, and Takeda Pharmaceutical., Speakers bureau: AbbVie, Actelion Pharmaceuticals Japan, Asahi Kasei Pharma, AYUMI Pharmaceutical, Bristol-Myers Squibb, Chugai Pharmaceutical, Eisai, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceutical, Mitsubishi Tanabe Pharma, Novartis Pharma, and Sanofi.
Collapse
|
15
|
Oie Y, Itoh Y, Kawamura M, Takase Y, Murao T, Ishihara S, Nomoto Y, Hirasawa N, Asano A, Yamakawa K, Ito J, Naganawa S. Clinical Results of T1 Glottic Cancer Treated with Radiotherapy Using 2.25 Gy per Fractions: A Multicenter Survey in Clinical Practice. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.1708] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
16
|
Idei H, Onchi T, Kariya T, Tsujimura T, Kubo S, Kobayashi S, Sakaguchi M, Imai T, Hasegawa M, Nakamura K, Mishra K, Fukuyama M, Yunoki M, Kojima S, Watanabe O, Kuroda K, Hanada K, Nagashima Y, Ejiri A, Matsumoto N, Ono M, Higashijima A, Nagata T, Shimabukoro S, Takase Y, Fukuyama A, Murakami S. 28-GHz ECHCD system with beam focusing launcher on the QUEST spherical tokamak. Fusion Engineering and Design 2019. [DOI: 10.1016/j.fusengdes.2019.02.027] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
17
|
Kawamura M, Koide Y, Murai T, Ishihara S, Takase Y, Murao T, Okazaki D, Yamaguchi T, Uchiyama K, Itoh Y, Kodaira T, Shibamoto Y, Mizuno M, Kikkawa F, Naganawa S. Should Small Cell Carcinoma of the Cervix be Treated As Localized Small Cell Cancer or Advanced Cervical Cancer: A Retrospective Multi-Institutional Cohort Study. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.1809] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
18
|
Takahashi K, Ozawa E, Nakao K, Aoki S, Takase Y. Hepatobiliary and Pancreatic: A procalcitonin-secreting and calcitonin-secreting pancreatic neuroendocrine carcinoma. J Gastroenterol Hepatol 2019; 34:964. [PMID: 30663800 DOI: 10.1111/jgh.14568] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/18/2018] [Accepted: 12/08/2018] [Indexed: 01/24/2023]
Affiliation(s)
- K Takahashi
- Department of Internal Medicine, NHO Saga Hospital, Saga, Japan.,Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
| | - E Ozawa
- Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
| | - K Nakao
- Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
| | - S Aoki
- Department of Pathology and Microbiology, Graduate School of Biomedical Sciences, Saga University, Saga, Japan
| | - Y Takase
- Department of Pathology and Microbiology, Graduate School of Biomedical Sciences, Saga University, Saga, Japan
| |
Collapse
|
19
|
Kimura K, Itoh Y, Okada T, Kubota S, Kawamura M, Nakahara R, Oie Y, Kozai Y, Takase Y, Tsuzuki H, Nishio N, Hiramatsu M, Fujimoto Y, Mizutani T, Naganawa S. Optimized treatment strategy of radiotherapy for early glottic squamous cell carcinomas: An initial analysis. Nagoya J Med Sci 2018; 79:331-338. [PMID: 28878438 PMCID: PMC5577019 DOI: 10.18999/nagjms.79.3.331] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/02/2022]
Abstract
The purpose of this study was to evaluate the clinical outcomes of radiotherapy for patients with T1/T2 glottic carcinoma. Patients with T1/T2 glottic carcinoma histopathologically diagnosed with squamous cell carcinoma and treated at our hospital between 2007 and 2015 were analyzed retrospectively. Our strategy for T1/T2 glottic carcinoma was as follows: radiotherapy alone with 2.25 Gy per fraction to a total of 25–28 fractions for patients with non-bulky T1 glottic carcinoma; concurrent chemoradiotherapy with oral S-1 and radiotherapy with 2 Gy per fraction to a total of 30 fractions for patients with T1 bulky/T2 favorable glottic carcinoma; or chemoradiotherapy with high-dose cisplatin and radiotherapy with 2 Gy per fraction to a total of 35 fractions for T2 unfavorable glottic carcinoma. Forty-eight patients were eligible. The median follow-up period among surviving patients was 38 months (range, 11–107). The disease was T1a in 23%, T1b in 13%, and T2 in 65% of patients. The 3-year local control rate in all patients, T1a, T1b, and T2 was 96.7%, 100%, 100%, and 96.0%, respectively. Of the 46 patients, one with T2 glottic carcinoma developed recurrent disease at the primary site, and one with T2 glottic carcinoma had lymph node recurrences in the neck. Acute Grade 3 dermatitis occurred in 8 (17%) patients and late Grade 2 hypothyroidism occurred in 2 (4%) patients. This retrospective study shows that our optimized treatment strategy of radiotherapy depending on the stage of early glottic carcinoma is not only effective but also well-tolerated.
Collapse
Affiliation(s)
- Kana Kimura
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Yoshiyuki Itoh
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Tohru Okada
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Seiji Kubota
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Mariko Kawamura
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Rie Nakahara
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Yumi Oie
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Yuka Kozai
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Yuuki Takase
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Hidenori Tsuzuki
- Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Naoki Nishio
- Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Mariko Hiramatsu
- Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Yasushi Fujimoto
- Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Takefumi Mizutani
- Department of Clinical Oncology and Chemotherapy, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Shinji Naganawa
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| |
Collapse
|
20
|
Yamazaki H, Delgado-Aparicio LF, Groebner R, Grierson B, Hill K, Pablant N, Stratton B, Efthimion P, Ejiri A, Takase Y, Ono M. A computational tool for simulation and design of tangential multi-energy soft x-ray pin-hole cameras for tokamak plasmas. Rev Sci Instrum 2018; 89:10G120. [PMID: 30399783 DOI: 10.1063/1.5038788] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/05/2018] [Accepted: 07/12/2018] [Indexed: 06/08/2023]
Abstract
A new tool has been developed to calculate the spectral, spatial, and temporal responses of multi-energy soft x-ray (ME-SXR) pinhole cameras for arbitrary plasma densities (n e,D), temperature (T e), and impurity densities (n Z). ME-SXR imaging provides a unique opportunity for obtaining important plasma properties (e.g., T e, n Z, and Z eff) by measuring both continuum and line emission in multiple energy ranges. This technique employs a pixelated x-ray detector in which the lower energy threshold for photon detection can be adjusted independently. Simulations assuming a tangential geometry and DIII-D-like plasmas (e.g., n e,0 ≈ 8 × 1019 m-3 and T e,0 ≈ 2.8 keV) for various impurity (e.g., C, O, Ar, Ni, and Mo) density profiles have been performed. The computed brightnesses range from few 102 counts pixel-1 ms-1 depending on the cut-off energy thresholds, while the maximum allowable count rate is 104 counts pixel-1 ms-1. The typical spatial resolution in the mid-plane is ≈0.5 cm with a photon-energy resolution of 500 eV at a 500 Hz frame rate.
Collapse
Affiliation(s)
- H Yamazaki
- The University of Tokyo, Kashiwa 277-8561, Japan
| | | | - R Groebner
- General Atomics, San Diego, California 92121, USA
| | - B Grierson
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - K Hill
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - N Pablant
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - B Stratton
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - P Efthimion
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - A Ejiri
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - Y Takase
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - M Ono
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| |
Collapse
|
21
|
Delgado-Aparicio LF, Wallace J, Yamazaki H, VanMeter P, Reusch L, Nornberg M, Almagari A, Maddox J, Luethi B, Rissi M, Donath T, Den Hartog D, Sarff J, Weix P, Goetz J, Pablant N, Hill K, Stratton B, Efthimion P, Takase Y, Ejiri A, Ono M. Simulation, design, and first test of a multi-energy soft x-ray (SXR) pinhole camera in the Madison Symmetric Torus (MST). Rev Sci Instrum 2018; 89:10G116. [PMID: 30399822 DOI: 10.1063/1.5038798] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/05/2018] [Accepted: 06/20/2018] [Indexed: 06/08/2023]
Abstract
A multi-energy soft x-ray pinhole camera has been designed and built for the Madison Symmetric Torus reversed field pinch to aid the study of particle and thermal-transport, as well as MHD stability physics. This novel imaging diagnostic technique combines the best features from both pulse-height-analysis and multi-foil methods employing a PILATUS3 x-ray detector in which the lower energy threshold for photon detection can be adjusted independently on each pixel. Further improvements implemented on the new cooled systems allow a maximum count rate of 10 MHz per pixel and sensitivity to the strong Al and Ar emission between 1.5 and 4 keV. The local x-ray emissivity will be measured in multiple energy ranges simultaneously, from which it is possible to infer 1D and 2D simultaneous profile measurements of core electron temperature and impurity density profiles with no a priori assumptions of plasma profiles, magnetic field reconstruction constraints, high-density limitations, or need of shot-to-shot reproducibility. The expected time and space resolutions will be 2 ms and <1 cm, respectively.
Collapse
Affiliation(s)
| | - J Wallace
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - H Yamazaki
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - P VanMeter
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - L Reusch
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - M Nornberg
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - A Almagari
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - J Maddox
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - B Luethi
- DECTRIS Ltd., 5405 Baden-Dattwil, Switzerland
| | - M Rissi
- DECTRIS Ltd., 5405 Baden-Dattwil, Switzerland
| | - T Donath
- DECTRIS Ltd., 5405 Baden-Dattwil, Switzerland
| | - D Den Hartog
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - J Sarff
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - P Weix
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - J Goetz
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - N Pablant
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - K Hill
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - B Stratton
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - P Efthimion
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - Y Takase
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - A Ejiri
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - M Ono
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| |
Collapse
|
22
|
Kimura K, Itoh Y, Okada T, Kubota S, Kawamura M, Nakahara R, Oie Y, Kozai Y, Takase Y, Tsuzuki H, Nishio N, Hiramatsu M, Fujimoto Y, Mizutani T, Hirakawa A, Naganawa S. Study Protocol: Prospective Study of Concurrent Chemoradiotherapy with S-1 and Hypofractionated Radiotherapy for Outpatients with Early Glottic Squamous Cell Carcinomas. Asian Pac J Cancer Prev 2018; 19:1195-1199. [PMID: 29801401 PMCID: PMC6031847 DOI: 10.22034/apjcp.2018.19.5.1195] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
Background: The recommended treatment strategies for early glottic carcinoma with intent of larynx preservation are primarily radiotherapy. However, the outcomes of radiotherapy for bulky T1 or T2 glottic carcinoma are unsatisfactory. We designed a protocol consisting of concurrent chemoradiotherapy using S-1 as the radiosensitizer. We have performed this protocol in patients with favorable T2 lesions and demonstrated its efficacy and safety. In contrast, we have treated non-bulky T1 glottic carcinomas with 2.25 Gy per fraction, for a total of 25-28 fractions, starting in 2011 to improve efficacy and shorten the treatment period. Since this treatment strategy was implemented for T1 disease, no local failure has occurred to date, and it appears to be almost as safe as radiotherapy using 2.0 Gy per fraction. With the aim of improving the local control rate and shortening the treatment period primarily for favorable T2 disease, we changed the dose of radiation in our protocol from 2.0 Gy to 2.25 Gy per fraction, for a total of 25 fractions (from 30 fractions). The present study aims to evaluate the efficacy and safety of this new protocol. Methods: This study will be conducted as a clinical, prospective, single-armed, non-randomized trial. Patients are to receive S-1 (55.3 mg /m2 /day, once daily) and radiotherapy (2.25 Gy per fraction, for a total of 25 fractions). S-1 and radiotherapy are started on the same day that radiotherapy is performed, 3-6 hours after oral administration of S-1. The primary study aim is the 3-year local control rate. The secondary study aims are overall survival, voice-preservation survival, disease-free survival, complete response rate, completion rate, and toxicity. Result and conclusion: This is the first single-center, non-randomized, prospective study of concurrent chemoradiotherapy with S-1 and hypofractionated radiotherapy to be conducted. The trial will evaluate the efficacy and safety of our protocol.
Collapse
Affiliation(s)
- Kana Kimura
- Department of Radiology, Nagoya University Graduate School of Medicine 65 Tsurumai-cho, Shouwa-ku, Nagoya 4668550, Aichi, Japan.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Naito Y, Kawahara A, Okabe Y, Ishida Y, Sadashima E, Murata K, Takase Y, Abe H, Yamaguchi T, Tanigawa M, Mihara Y, Kondo R, Kusano H, Nakayama M, Shimamatsu K, Yano H, Akiba J. SurePath ® LBC improves the diagnostic accuracy of intrahepatic and hilar cholangiocarcinoma. Cytopathology 2018; 29:349-354. [PMID: 29723910 DOI: 10.1111/cyt.12565] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/03/2018] [Indexed: 01/22/2023]
Abstract
INTRODUCTION The current study aimed to compare cytology using SurePath® (SP)-LBC and biliary tissue histology (BTH) for the diagnosis of biliary disease. METHODS Between January 2014 and December 2016, 57 patients underwent endoscopic retrograde cholangiopancreatography for the diagnosis of biliary disease. Biliary cytological samples were processed using SP-LBC and subsequently BTH was performed. A final diagnosis was confirmed by surgery (23 malignant cases) and clinical follow-up (34 benign and malignant cases): 18 extrahepatic cholangiocarcinoma; 17 intrahepatic/hilar cholangiocarcinoma (intra/H-CC); eight other malignant disease; and 14 benign biliary disease. The diagnoses made using SP-LBC and BTH were classified into four categories: (1) benign; (2) indeterminate; (3) suspicious for malignancy/malignant; and (4) inadequate. In addition, diagnostic accuracy was compared between SP-LBC and BTH. RESULTS Although 23% (13/57) of BTH samples were classified as inadequate, all SP-LBC cases were classified as adequate. Among 43 malignant cases, 11 normal, four indeterminate and 28 suspicious for malignancy/malignant were found using SP-LBC (26%, 9% and 65%, respectively), in contrast to 10 inadequate, nine normal, 10 indeterminate and 14 suspicious for malignancy/malignant observed using BTH (23%, 21%, 23%, and 33%, respectively). The identification of malignant cells was strikingly different between SP-LBC and BTH. Furthermore, limited to intra/H-CC, accuracy was significantly higher using SP-LBC than using BTH (P < .001). CONCLUSIONS SP-LBC of the biliary tract is a useful and reliable method for diagnosing biliary malignant disease and has an advantage over BTH for detecting malignant cells and accurately diagnosing intra/H-CC.
Collapse
Affiliation(s)
- Y Naito
- Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan.,Department of Pathology, Kurume University School of Medicine, Kurume, Japan
| | - A Kawahara
- Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
| | - Y Okabe
- Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan
| | - Y Ishida
- Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan
| | - E Sadashima
- Shin-Koga Hospital, Medical Corporation Tenjinkai, Kurume, Japan
| | - K Murata
- Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
| | - Y Takase
- Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
| | - H Abe
- Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
| | - T Yamaguchi
- Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
| | - M Tanigawa
- Department of Pathology, Kurume University School of Medicine, Kurume, Japan
| | - Y Mihara
- Department of Pathology, Kurume University School of Medicine, Kurume, Japan
| | - R Kondo
- Department of Pathology, Kurume University School of Medicine, Kurume, Japan
| | - H Kusano
- Department of Pathology, Kurume University School of Medicine, Kurume, Japan
| | - M Nakayama
- Department of Pathology, Kurume University School of Medicine, Kurume, Japan
| | - K Shimamatsu
- Department of Pathology, Omuta City Hospital, Omuta, Japan
| | - H Yano
- Department of Pathology, Kurume University School of Medicine, Kurume, Japan
| | - J Akiba
- Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
| |
Collapse
|
24
|
Kawahara A, Fukumitsu C, Azuma K, Taira T, Abe H, Takase Y, Murata K, Sadashima E, Hattori S, Naito Y, Akiba J. Cover Image. Cytopathology 2018. [DOI: 10.1111/cyt.12543] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
25
|
Kawahara A, Fukumitsu C, Azuma K, Taira T, Abe H, Takase Y, Murata K, Sadashima E, Hattori S, Naito Y, Akiba J. A Combined test using both cell sediment and supernatant cell-free DNA in pleural effusion shows increased sensitivity in detecting activating EGFR mutation in lung cancer patients. Cytopathology 2018; 29:150-155. [PMID: 29363841 DOI: 10.1111/cyt.12517] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/23/2017] [Indexed: 12/28/2022]
Abstract
INTRODUCTION The aim of this study was to examine whether a combined test using both cell sediment and supernatant cytology cell-free DNA (ccfDNA) is more useful in detecting EGFR mutation than using cell sediment DNA or supernatant ccfDNA alone in pleural effusion of lung cancer patients. METHODS A total of 74 lung adenocarcinoma patients with paired samples between primary tumour and corresponding metastatic tumour with both cell sediment and supernatant ccfDNA of pleural effusion cytology were enrolled in this study. Cell sediment and supernatant ccfDNA were analysed separately for EGFR mutations by polymerase chain reaction. RESULTS Out of 45 patients with mutant EGFR in primary tumours, EGFR mutations were detected in 23 cell sediments of corresponding metastases (sensitivity; 51.1%) and 20 supernatant ccfDNA corresponding metastases (sensitivity; 44.4%). By contrast, the combined test detected EGFR mutations in 27 corresponding metastases (sensitivity; 60.0%), and had a higher sensitivity than the cell sediment or the supernatant ccfDNA alone (P < .05). Out of 45 patients with mutant EGFR, 24, three and 18 were cytologically diagnosed as positive, atypical or negative, respectively. The detection rate in the combined test was highest (95.8%) in the positive group, and mutant EGFR was also detected in four of 18 samples (22.2%) in the negative group. CONCLUSIONS A combined test using both cell sediment DNA and supernatant ccfDNA samples increases the concordance rate of EGFR mutations between primary tumour and corresponding metastases. Our findings indicate that supernatant ccfDNA is useful even in cases where the cytological diagnosis is negative.
Collapse
Affiliation(s)
- A Kawahara
- Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
| | - C Fukumitsu
- Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
| | - K Azuma
- Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan
| | - T Taira
- Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
| | - H Abe
- Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
| | - Y Takase
- Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
| | - K Murata
- Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
| | - E Sadashima
- Department of Clinical Laboratory, Tenjinkai Shin-Koga Hospital, Kurume, Japan
| | - S Hattori
- Department of Integrated Medicine, Biomedical Statistics, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Y Naito
- Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
| | - J Akiba
- Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
| |
Collapse
|
26
|
Wang Z, Hanada K, Yoshida N, Shimoji T, Miyamoto M, Oya Y, Zushi H, Idei H, Nakamura K, Fujisawa A, Nagashima Y, Hasegawa M, Kawasaki S, Higashijima A, Nakashima H, Nagata T, Kawaguchi A, Fujiwara T, Araki K, Mitarai O, Fukuyama A, Takase Y, Matsumoto K. Measurement of thickness of film deposited on the plasma-facing wall in the QUEST tokamak by colorimetry. Rev Sci Instrum 2017; 88:093502. [PMID: 28964174 DOI: 10.1063/1.5000739] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/21/2016] [Accepted: 08/17/2017] [Indexed: 06/07/2023]
Abstract
After several experimental campaigns in the Kyushu University Experiment with Steady-state Spherical Tokamak (QUEST), the originally stainless steel plasma-facing wall (PFW) becomes completely covered with a deposited film composed of mixture materials, such as iron, chromium, carbon, and tungsten. In this work, an innovative colorimetry-based method was developed to measure the thickness of the deposited film on the actual QUEST wall. Because the optical constants of the deposited film on the PFW were position-dependent and the extinction coefficient k1 was about 1.0-2.0, which made the probing light not penetrate through some thick deposited films, the colorimetry method developed can only provide a rough value range of thickness of the metal-containing film deposited on the actual PFW in QUEST. However, the use of colorimetry is of great benefit to large-area inspections and to radioactive materials in future fusion devices that will be strictly prohibited from being taken out of the limited area.
Collapse
Affiliation(s)
- Z Wang
- Interdisciplinary Graduate School of Engineering Sciences, Kyushu University, Kasuga, Fukuoka 816-8580, Japan
| | - K Hanada
- Research Institute for Applied Mechanics, Kyushu University, Kasuga, Fukuoka 816-8580, Japan
| | - N Yoshida
- Research Institute for Applied Mechanics, Kyushu University, Kasuga, Fukuoka 816-8580, Japan
| | - T Shimoji
- Interdisciplinary Graduate School of Engineering Sciences, Kyushu University, Kasuga, Fukuoka 816-8580, Japan
| | - M Miyamoto
- Department of Material Science, Shimane University, Matsue, Shimane 690-8504, Japan
| | - Y Oya
- Faculty of Science, Shizuoka University, Ohya, Shizuoaka 422-8529, Japan
| | - H Zushi
- Research Institute for Applied Mechanics, Kyushu University, Kasuga, Fukuoka 816-8580, Japan
| | - H Idei
- Research Institute for Applied Mechanics, Kyushu University, Kasuga, Fukuoka 816-8580, Japan
| | - K Nakamura
- Research Institute for Applied Mechanics, Kyushu University, Kasuga, Fukuoka 816-8580, Japan
| | - A Fujisawa
- Research Institute for Applied Mechanics, Kyushu University, Kasuga, Fukuoka 816-8580, Japan
| | - Y Nagashima
- Research Institute for Applied Mechanics, Kyushu University, Kasuga, Fukuoka 816-8580, Japan
| | - M Hasegawa
- Research Institute for Applied Mechanics, Kyushu University, Kasuga, Fukuoka 816-8580, Japan
| | - S Kawasaki
- Research Institute for Applied Mechanics, Kyushu University, Kasuga, Fukuoka 816-8580, Japan
| | - A Higashijima
- Research Institute for Applied Mechanics, Kyushu University, Kasuga, Fukuoka 816-8580, Japan
| | - H Nakashima
- Research Institute for Applied Mechanics, Kyushu University, Kasuga, Fukuoka 816-8580, Japan
| | - T Nagata
- Research Institute for Applied Mechanics, Kyushu University, Kasuga, Fukuoka 816-8580, Japan
| | - A Kawaguchi
- Research Institute for Applied Mechanics, Kyushu University, Kasuga, Fukuoka 816-8580, Japan
| | - T Fujiwara
- Research Institute for Applied Mechanics, Kyushu University, Kasuga, Fukuoka 816-8580, Japan
| | - K Araki
- Research Institute for Applied Mechanics, Kyushu University, Kasuga, Fukuoka 816-8580, Japan
| | - O Mitarai
- Institute of Industrial Science and Technology Research, Tokai University, Kumamoto 862-8652, Japan
| | - A Fukuyama
- Department of Nuclear Engineering, Kyoto University, Kyoto 606-8501, Japan
| | - Y Takase
- Graduate School of Frontier Sciences, University of Tokyo, Kashiwa, Chiba 277-8561, Japan
| | - K Matsumoto
- Honda R&D Co., Ltd. Automobile R&D Center, Haga, Tochigi 321-3393, Japan
| |
Collapse
|
27
|
Ejiri A, Oosako T, Tsujimura J, Shimada Y, Takase Y, Torii Y, Sasaki M, Tojo H, Masuda T, Nuga H, Sumitomo N, Kainaga S, Sugiyama J, Tsujii N. ECH and HHFW Start-Up Experiments on the TST-2 Spherical Tokamak. Fusion Science and Technology 2017. [DOI: 10.13182/fst07-a1341] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- A. Ejiri
- Grad. School of Frontier Sciences and Grad. School of Science, the Univ. Tokyo, Kashiwa 277-8561, Japan
| | - T. Oosako
- Grad. School of Frontier Sciences and Grad. School of Science, the Univ. Tokyo, Kashiwa 277-8561, Japan
| | - J. Tsujimura
- Grad. School of Frontier Sciences and Grad. School of Science, the Univ. Tokyo, Kashiwa 277-8561, Japan
| | - Y. Shimada
- Grad. School of Frontier Sciences and Grad. School of Science, the Univ. Tokyo, Kashiwa 277-8561, Japan
| | - Y. Takase
- Grad. School of Frontier Sciences and Grad. School of Science, the Univ. Tokyo, Kashiwa 277-8561, Japan
| | - Y. Torii
- Grad. School of Frontier Sciences and Grad. School of Science, the Univ. Tokyo, Kashiwa 277-8561, Japan
| | - M. Sasaki
- Grad. School of Frontier Sciences and Grad. School of Science, the Univ. Tokyo, Kashiwa 277-8561, Japan
| | - H. Tojo
- Grad. School of Frontier Sciences and Grad. School of Science, the Univ. Tokyo, Kashiwa 277-8561, Japan
| | - T. Masuda
- Grad. School of Frontier Sciences and Grad. School of Science, the Univ. Tokyo, Kashiwa 277-8561, Japan
| | - H. Nuga
- Grad. School of Frontier Sciences and Grad. School of Science, the Univ. Tokyo, Kashiwa 277-8561, Japan
| | - N. Sumitomo
- Grad. School of Frontier Sciences and Grad. School of Science, the Univ. Tokyo, Kashiwa 277-8561, Japan
| | - S. Kainaga
- Grad. School of Frontier Sciences and Grad. School of Science, the Univ. Tokyo, Kashiwa 277-8561, Japan
| | - J. Sugiyama
- Grad. School of Frontier Sciences and Grad. School of Science, the Univ. Tokyo, Kashiwa 277-8561, Japan
| | - N. Tsujii
- Grad. School of Frontier Sciences and Grad. School of Science, the Univ. Tokyo, Kashiwa 277-8561, Japan
| |
Collapse
|
28
|
Seki T, Mutoh T, Kumazawa R, Saito K, Nakamura Y, Sakamoto M, Watanabe T, Kubo S, Shimozuma T, Yoshimura Y, Igami H, Ohkubo K, Takeiri Y, Oka Y, Tsumori K, Osakabe M, Ikeda K, Nagaoka K, Kaneko O, Miyazawa J, Morita S, Narihara K, Shoji M, Masuzaki S, Goto M, Morisaki T, Peterson BJ, Sato K, Tokuzawa T, Ashikawa N, Nishimura K, Funaba H, Chikaraishi H, Takeuchi N, Notake T, Ogawa H, Torii Y, Shimpo F, Nomura G, Yokota M, Takahashi C, Kato A, Takase Y, Kasahara H, Ichimura M, Higaki H, Zhao YP, Kwak JG, Yamada H, Kawahata K, Ohyabu N, Ida K, Nagayama Y, Noda N, Watari T, Komori A, Sudo S, Motojima O. Study of Long-Pulse Plasma Experiment Using ICRF Heating in LHD. Fusion Science and Technology 2017. [DOI: 10.13182/fst06-a1234] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- T. Seki
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - T. Mutoh
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - R. Kumazawa
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Saito
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - Y. Nakamura
- National Institute for Fusion Science, Toki 509-5292, Japan
| | | | - T. Watanabe
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - S. Kubo
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - T. Shimozuma
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - Y. Yoshimura
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - H. Igami
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Ohkubo
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - Y. Takeiri
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - Y. Oka
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Tsumori
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - M. Osakabe
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Ikeda
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Nagaoka
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - O. Kaneko
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - J. Miyazawa
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - S. Morita
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Narihara
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - M. Shoji
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - S. Masuzaki
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - M. Goto
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - T. Morisaki
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - B. J. Peterson
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Sato
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - T. Tokuzawa
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - N. Ashikawa
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Nishimura
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - H. Funaba
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - H. Chikaraishi
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - N. Takeuchi
- Nagoya University, Faculty of Engineering, Nagoya 464-8601, Japan
| | - T. Notake
- Nagoya University, Faculty of Engineering, Nagoya 464-8601, Japan
| | - H. Ogawa
- Graduate University for Advanced Studies, Hayama 240-0162, Japan
| | - Y. Torii
- Kyoto University, Institute of Advanced Energy, Uji 611-0011, Japan
| | - F. Shimpo
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - G. Nomura
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - M. Yokota
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - C. Takahashi
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - A. Kato
- National Institute for Fusion Science, Toki 509-5292, Japan
| | | | | | | | - H. Higaki
- University of Tsukuba, Tsukuba, Japan
| | - Y. P. Zhao
- Institute of Plasma Physics, Academia Sinica, Hefei 230031, P.R. China
| | - J. G. Kwak
- Korea Atomic Energy Research Institute, Daejeon 305-600, Korea Rep
| | - H. Yamada
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Kawahata
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - N. Ohyabu
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Ida
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - Y. Nagayama
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - N. Noda
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - T. Watari
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - A. Komori
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - S. Sudo
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - O. Motojima
- National Institute for Fusion Science, Toki 509-5292, Japan
| | | |
Collapse
|
29
|
Motojima O, Yamada H, Komori A, Watanabe KY, Mutoh T, Takeiri Y, Ida K, Akiyama T, Asakura N, Ashikawa N, Chikaraishi H, Cooper WA, Emoto M, Fujita T, Fujiwara M, Funaba H, Goncharov P, Goto M, Hamada Y, Higashijima S, Hino T, Hoshino M, Ichimura M, Idei H, Ido T, Ikeda K, Imagawa S, Inagaki S, Isayama A, Isobe M, Itoh T, Itoh K, Kado S, Kalinina D, Kaneba T, Kaneko O, Kato D, Kato T, Kawahata K, Kawashima H, Kawazome H, Kobuchi T, Kondo K, Kubo S, Kumazawa R, Lyon JF, Maekawa R, Mase A, Masuzaki S, Mito T, Matsuoka K, Miura Y, Miyazawa J, More R, Morisaki T, Morita S, Murakami I, Murakami S, Mutoh S, Nagaoka K, Nagasaki K, Nagayama Y, Nakamura Y, Nakanishi H, Narihara K, Narushima Y, Nishimura H, Nishimura K, Nishiura M, Nishizawa A, Noda N, Notake T, Nozato H, Ohdachi S, Ohkubo K, Ohyabu N, Oyama N, Oka Y, Okada H, Osakabe M, Ozaki T, Peterson BJ, Sagara A, Saida T, Saito K, Sakakibara S, Sakamoto M, Sakamoto R, Sasao M, Sato K, Seki T, Shimozuma T, Shoji M, Sudo S, Takagi S, Takahashi Y, Takase Y, Takenaga H, Takeuchi N, Tamura N, Tanaka K, Tanaka M, Toi K, Takahata K, Tokuzawa T, Torii Y, Tsumori K, Watanabe F, Watanabe M, Watanabe T, Watari T, Yamada I, Yamada S, Yamaguchi T, Yamamoto S, Yamazaki K, Yanagi N, Yokoyama M, Yoshida N, Yoshimura S, Yoshimura Y, Yoshinuma M. Review on the Progress of the LHD Experiment. Fusion Science and Technology 2017. [DOI: 10.13182/fst04-a535] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- O. Motojima
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - H. Yamada
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - A. Komori
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - K. Y. Watanabe
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - T. Mutoh
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - Y. Takeiri
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - K. Ida
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - T. Akiyama
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - N. Asakura
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - N. Ashikawa
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - H. Chikaraishi
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - W. A. Cooper
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - M. Emoto
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - T. Fujita
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - M. Fujiwara
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - H. Funaba
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - P. Goncharov
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - M. Goto
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - Y. Hamada
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - S. Higashijima
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - T. Hino
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - M. Hoshino
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - M. Ichimura
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - H. Idei
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - T. Ido
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - K. Ikeda
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - S. Imagawa
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - S. Inagaki
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - A. Isayama
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - M. Isobe
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - T. Itoh
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - K. Itoh
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - S. Kado
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - D. Kalinina
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - T. Kaneba
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - O. Kaneko
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - D. Kato
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - T. Kato
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - K. Kawahata
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - H. Kawashima
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - H. Kawazome
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - T. Kobuchi
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - K. Kondo
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - S. Kubo
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - R. Kumazawa
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - J. F. Lyon
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - R. Maekawa
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - A. Mase
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - S. Masuzaki
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - T. Mito
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - K. Matsuoka
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - Y. Miura
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - J. Miyazawa
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - R. More
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - T. Morisaki
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - S. Morita
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - I. Murakami
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - S. Murakami
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - S. Mutoh
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - K. Nagaoka
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - K. Nagasaki
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - Y. Nagayama
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - Y. Nakamura
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - H. Nakanishi
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - K. Narihara
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - Y. Narushima
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - H. Nishimura
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - K. Nishimura
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - M. Nishiura
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - A. Nishizawa
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - N. Noda
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - T. Notake
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - H. Nozato
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - S. Ohdachi
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - K. Ohkubo
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - N. Ohyabu
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - N. Oyama
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - Y. Oka
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - H. Okada
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - M. Osakabe
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - T. Ozaki
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - B. J. Peterson
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - A. Sagara
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - T. Saida
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - K. Saito
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - S. Sakakibara
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - M. Sakamoto
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - R. Sakamoto
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - M. Sasao
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - K. Sato
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - T. Seki
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - T. Shimozuma
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - M. Shoji
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - S. Sudo
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - S. Takagi
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - Y. Takahashi
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - Y. Takase
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - H. Takenaga
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - N. Takeuchi
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - N. Tamura
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - K. Tanaka
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - M. Tanaka
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - K. Toi
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - K. Takahata
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - T. Tokuzawa
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - Y. Torii
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - K. Tsumori
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - F. Watanabe
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - M. Watanabe
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - T. Watanabe
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - T. Watari
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - I. Yamada
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - S. Yamada
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - T. Yamaguchi
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - S. Yamamoto
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - K. Yamazaki
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - N. Yanagi
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - M. Yokoyama
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - N. Yoshida
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - S. Yoshimura
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - Y. Yoshimura
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| | - M. Yoshinuma
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
| |
Collapse
|
30
|
Ames T, Slusher B, Wozniak K, Takase Y, Shimizu H, Nishibata-Kobayashi K, Kanada-Sonobe R, Kerns W, Fong K, Pourquier P, Gongora C, Jimeno J, Chatterjee D. Findings across pre-clinical models in the development of PT-112, a novel investigational platinum-pyrophosphate anti-cancer agent. Eur J Cancer 2016. [DOI: 10.1016/s0959-8049(16)33054-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
31
|
Tojo H, Yamada I, Yasuhara R, Ejiri A, Hiratsuka J, Togashi H, Yatsuka E, Hatae T, Funaba H, Hayashi H, Takase Y, Itami K. Validations of calibration-free measurements of electron temperature using double-pass Thomson scattering diagnostics from theoretical and experimental aspects. Rev Sci Instrum 2016; 87:093502. [PMID: 27782603 DOI: 10.1063/1.4961476] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
This paper evaluates the accuracy of electron temperature measurements and relative transmissivities of double-pass Thomson scattering diagnostics. The electron temperature (Te) is obtained from the ratio of signals from a double-pass scattering system, then relative transmissivities are calculated from the measured Te and intensity of the signals. How accurate the values are depends on the electron temperature (Te) and scattering angle (θ), and therefore the accuracy of the values was evaluated experimentally using the Large Helical Device (LHD) and the Tokyo spherical tokamak-2 (TST-2). Analyzing the data from the TST-2 indicates that a high Te and a large scattering angle (θ) yield accurate values. Indeed, the errors for scattering angle θ = 135° are approximately half of those for θ = 115°. The method of determining the Te in a wide Te range spanning over two orders of magnitude (0.01-1.5 keV) was validated using the experimental results of the LHD and TST-2. A simple method to provide relative transmissivities, which include inputs from collection optics, vacuum window, optical fibers, and polychromators, is also presented. The relative errors were less than approximately 10%. Numerical simulations also indicate that the Te measurements are valid under harsh radiation conditions. This method to obtain Te can be considered for the design of Thomson scattering systems where there is high-performance plasma that generates harsh radiation environments.
Collapse
Affiliation(s)
- H Tojo
- National Institutes for Quantum and Radiological Science and Technology, 801-1 Mukoyama, Naka 311-0193, Japan
| | - I Yamada
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki 509-5292, Japan
| | - R Yasuhara
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki 509-5292, Japan
| | - A Ejiri
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - J Hiratsuka
- National Institutes for Quantum and Radiological Science and Technology, 801-1 Mukoyama, Naka 311-0193, Japan
| | - H Togashi
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - E Yatsuka
- National Institutes for Quantum and Radiological Science and Technology, 801-1 Mukoyama, Naka 311-0193, Japan
| | - T Hatae
- National Institutes for Quantum and Radiological Science and Technology, 801-1 Mukoyama, Naka 311-0193, Japan
| | - H Funaba
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki 509-5292, Japan
| | - H Hayashi
- National Institute for Fusion Science, 322-6 Oroshi-cho, Toki 509-5292, Japan
| | - Y Takase
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - K Itami
- National Institutes for Quantum and Radiological Science and Technology, 801-1 Mukoyama, Naka 311-0193, Japan
| |
Collapse
|
32
|
Furui H, Ejiri A, Nagashima Y, Takase Y, Sonehara M, Tsujii N, Yamaguchi T, Shinya T, Togashi H, Homma H, Nakamura K, Takeuchi T, Yajima S, Yoshida Y, Toida K, Takahashi W, Yamazaki H. A model of plasma current through a hole of Rogowski probe including sheath effects. Review of Scientific Instruments 2016; 87:043503. [PMID: 27131670 DOI: 10.1063/1.4944941] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
In TST-2 Ohmic discharges, local current is measured using a Rogowski probe by changing the angle between the local magnetic field and the direction of the hole of the Rogowski probe. The angular dependence shows a peak when the direction of the hole is almost parallel to the local magnetic field. The obtained width of the peak was broader than that of the theoretical curve expected from the probe geometry. In order to explain this disagreement, we consider the effect of sheath in the vicinity of the Rogowski probe. A sheath model was constructed and electron orbits were numerically calculated. From the calculation, it was found that the electron orbit is affected by E × B drift due to the sheath electric field. Such orbit causes the broadening of the peak in the angular dependence and the dependence agrees with the experimental results. The dependence of the broadening on various plasma parameters was studied numerically and explained qualitatively by a simplified analytical model.
Collapse
Affiliation(s)
- H Furui
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - A Ejiri
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | | | - Y Takase
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - M Sonehara
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - N Tsujii
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - T Yamaguchi
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - T Shinya
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - H Togashi
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - H Homma
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - K Nakamura
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - T Takeuchi
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - S Yajima
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - Y Yoshida
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - K Toida
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - W Takahashi
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - H Yamazaki
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| |
Collapse
|
33
|
|
34
|
Shevchenko V, Baranov Y, Bigelow T, Caughman J, Diem S, Dukes C, Finburg P, Hawes J, Gurl C, Griffiths J, Mailloux J, Peng M, Saveliev A, Takase Y, Tanaka H, Taylor G. Long Pulse EBW Start-up Experiments in MAST. EPJ Web of Conferences 2015. [DOI: 10.1051/epjconf/20158702007] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
35
|
Furui H, Nagashima Y, Takase Y, Ejiri A, Kakuda H, Sonehara M, Oosako T, Tsujii N, Hiratsuka J, Imamura K, Inada T, Nakamura K, Nakanishi A, Shinya T, Togashi H, Tsuda S, Wakatsuki T, Yamaguchi T. Local current density measurement using a Rogowski probe in Tokyo Spherical Tokamak-2. Rev Sci Instrum 2014; 85:11D813. [PMID: 25430226 DOI: 10.1063/1.4887277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
A Rogowski probe consisting of a small multi-layer Rogowski coil, five magnetic pick-up coils, and a Langmuir probe was developed to measure the local current density and its direction. It can be moved along the major radius and can be turned around its axis. This probe was used to measure the current density profile near the last closed flux surface of Ohmic plasmas in Tokyo Spherical Tokamak-2. The current density profile was measured successfully with a signal to noise ratio of greater than 20.
Collapse
Affiliation(s)
- H Furui
- The University of Tokyo, 5-1-5 Kasshiwanoha, Kashiwa, Chiba 277-8561, Japan
| | - Y Nagashima
- Kyushu University, 6-1 Kasuga-koen, Kasuga, Fukuoka 816-8680, Japan
| | - Y Takase
- The University of Tokyo, 5-1-5 Kasshiwanoha, Kashiwa, Chiba 277-8561, Japan
| | - A Ejiri
- The University of Tokyo, 5-1-5 Kasshiwanoha, Kashiwa, Chiba 277-8561, Japan
| | - H Kakuda
- The University of Tokyo, 5-1-5 Kasshiwanoha, Kashiwa, Chiba 277-8561, Japan
| | - M Sonehara
- The University of Tokyo, 5-1-5 Kasshiwanoha, Kashiwa, Chiba 277-8561, Japan
| | - T Oosako
- The University of Tokyo, 5-1-5 Kasshiwanoha, Kashiwa, Chiba 277-8561, Japan
| | - N Tsujii
- The University of Tokyo, 5-1-5 Kasshiwanoha, Kashiwa, Chiba 277-8561, Japan
| | - J Hiratsuka
- The University of Tokyo, 5-1-5 Kasshiwanoha, Kashiwa, Chiba 277-8561, Japan
| | - K Imamura
- The University of Tokyo, 5-1-5 Kasshiwanoha, Kashiwa, Chiba 277-8561, Japan
| | - T Inada
- The University of Tokyo, 5-1-5 Kasshiwanoha, Kashiwa, Chiba 277-8561, Japan
| | - K Nakamura
- The University of Tokyo, 5-1-5 Kasshiwanoha, Kashiwa, Chiba 277-8561, Japan
| | - A Nakanishi
- The University of Tokyo, 5-1-5 Kasshiwanoha, Kashiwa, Chiba 277-8561, Japan
| | - T Shinya
- The University of Tokyo, 5-1-5 Kasshiwanoha, Kashiwa, Chiba 277-8561, Japan
| | - H Togashi
- The University of Tokyo, 5-1-5 Kasshiwanoha, Kashiwa, Chiba 277-8561, Japan
| | - S Tsuda
- The University of Tokyo, 5-1-5 Kasshiwanoha, Kashiwa, Chiba 277-8561, Japan
| | - T Wakatsuki
- The University of Tokyo, 5-1-5 Kasshiwanoha, Kashiwa, Chiba 277-8561, Japan
| | - T Yamaguchi
- The University of Tokyo, 5-1-5 Kasshiwanoha, Kashiwa, Chiba 277-8561, Japan
| |
Collapse
|
36
|
Togashi H, Ejiri A, Hiratsuka J, Nakamura K, Takase Y, Yamaguchi T, Furui H, Imamura K, Inada T, Kakuda H, Nakanishi A, Oosako T, Shinya T, Sonehara M, Tsuda S, Tsujii N, Wakatsuki T, Hasegawa M, Nagashima Y, Narihara K, Yamada I, Tojo H. Demonstration of improvement in the signal-to-noise ratio of Thomson scattering signal obtained by using a multi-pass optical cavity on the Tokyo Spherical Tokamak-2. Rev Sci Instrum 2014; 85:11D846. [PMID: 25430259 DOI: 10.1063/1.4891707] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
The multi-pass Thomson scattering (TS) scheme enables obtaining many photons by accumulating multiple TS signals. The signal-to-noise ratio (SNR) depends on the accumulation number. In this study, we performed multi-pass TS measurements for ohmically heated plasmas, and the relationship between SNR and the accumulation number was investigated. As a result, improvement of SNR in this experiment indicated similar tendency to that calculated for the background noise dominant situation.
Collapse
Affiliation(s)
- H Togashi
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - A Ejiri
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - J Hiratsuka
- Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan
| | - K Nakamura
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - Y Takase
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - T Yamaguchi
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - H Furui
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - K Imamura
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - T Inada
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - H Kakuda
- Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan
| | - A Nakanishi
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - T Oosako
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - T Shinya
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - M Sonehara
- Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan
| | - S Tsuda
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - N Tsujii
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - T Wakatsuki
- Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan
| | - M Hasegawa
- Research Institute of Applied Mechanics, Kyushu University, Kasuga 816-8580, Japan
| | - Y Nagashima
- Research Institute of Applied Mechanics, Kyushu University, Kasuga 816-8580, Japan
| | - K Narihara
- Research Institute of Applied Mechanics, Kyushu University, Kasuga 816-8580, Japan
| | - I Yamada
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - H Tojo
- Japan Atomic Energy Agency, Naka 311-0193, Japan
| |
Collapse
|
37
|
Togashi H, Ejiri A, Hiratsuka J, Nakamura K, Takase Y, Yamaguchi T, Furui H, Imamura K, Inada T, Kakuda H, Nakanishi A, Oosako T, Shinya T, Sonehara M, Tsuda S, Tsujii N, Wakatsuki T, Hasegawa M, Nagashima Y, Narihara K, Yamada I, Tojo H. Note: Multi-pass Thomson scattering measurement on the TST-2 spherical tokamak. Rev Sci Instrum 2014; 85:056103. [PMID: 24880428 DOI: 10.1063/1.4878260] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
In multi-pass Thomson scattering (TS) scheme, a laser pulse makes multiple round trips through the plasma, and the effective laser energy is enhanced, and we can increase the signal-to-noise ratio as a result. We have developed a coaxial optical cavity in which a laser pulse is confined, and we performed TS measurements using the coaxial cavity in tokamak plasmas for the first time. In the optical cavity, the laser energy attenuation was approximately 30% in each round trip, and we achieved a photon number gain of about 3 compared with that obtained in the first round trip. In addition, the temperature measurement accuracy was improved by accumulating the first three round trip waveforms.
Collapse
Affiliation(s)
- H Togashi
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - A Ejiri
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - J Hiratsuka
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - K Nakamura
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - Y Takase
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - T Yamaguchi
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - H Furui
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - K Imamura
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - T Inada
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - H Kakuda
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - A Nakanishi
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - T Oosako
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - T Shinya
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - M Sonehara
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - S Tsuda
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - N Tsujii
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - T Wakatsuki
- The University of Tokyo, Kashiwa 277-8561, Japan
| | - M Hasegawa
- Kyushu University, Kasuga 816-8580, Japan
| | | | - K Narihara
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - I Yamada
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - H Tojo
- Japan Atomic Energy Agency, Naka 311-0193, Japan
| |
Collapse
|
38
|
Kamio S, Suzuki N, Cao QH, Watanabe TG, Abe K, Sakumura M, Ishiguchi K, Imazawa R, Yamada T, Inomoto M, Takase Y, Ono Y. Development of multi-channel Doppler spectroscopic measurement system using 8 × 8 multianode photomultiplier tube assembly. Rev Sci Instrum 2012; 83:083103. [PMID: 22938270 DOI: 10.1063/1.4739774] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Using an 8 × 8 channel photomultiplier tube assembly and a single Czerny-Turner monochromator, we have developed a novel Doppler spectroscopic system which can measure the time evolutions of spectral distribution of plasma emission from eight different lines of sight simultaneously. An optical lens system is employed to couple the output of the monochromator with the detector assembly, resulting in small cross-talks less than 5% in spatial distribution together with large magnification of up to 50 in wavelength direction. The suggested system yields cost-effective polychromatic measurements of eight spatial channels with uniform optical and electrical characteristics.
Collapse
Affiliation(s)
- S Kamio
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Oka T, Yakushiji Y, Nanri Y, Takase Y, Hara H. Teaching NeuroImages:Simultaneous angiography and ultrasonography in extracranial internal carotid artery dissection. Neurology 2012; 78:e150. [DOI: 10.1212/wnl.0b013e318259e249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
40
|
Tojo H, Ejiri A, Hiratsuka J, Yamaguchi T, Takase Y, Itami K, Hatae T. First measurement of electron temperature from signal ratios in a double-pass Thomson scattering system. Rev Sci Instrum 2012; 83:023507. [PMID: 22380091 DOI: 10.1063/1.3685612] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
This paper presents an experimental demonstration to determine electron temperature (T(e)) with unknown spectral sensitivity (transmissivity) in a Thomson scattering system. In this method, a double-pass scattering configuration is used and the scattered lights from each pass (with different scattering angles) are measured separately. T(e) can be determined from the ratio of the signal intensities without knowing a real chromatic dependence in the sensitivity. Note that the wavelength range for each spectral channel must be known. This method was applied to the TST-2 Thomson scattering system. As a result, T(e) measured from the ratio (T(e,r)) and T(e) measured from a standard method (T(e,s)) showed a good agreement with <∣T(e,r) - T(e,s)∣∕T(e,s)> = 7.3%.
Collapse
Affiliation(s)
- H Tojo
- Japan Atomic Energy Agency, 801-1 Mukoyama, Naka 311-0193, Japan.
| | | | | | | | | | | | | |
Collapse
|
41
|
Sharma SK, Zushi H, Takagi I, Hisano Y, Shikama T, Morita S, Tanabe T, Yoshida N, Sakamoto M, Higashizono Y, Hanada K, Hasegawa M, Mitarai O, Nakamura K, Idei H, Sato KN, Kawasaki S, Nakashima H, Higashijima A, Nakashima Y, Nishino N, Hatano Y, Sagara A, Nakamura Y, Ashikawa N, Maekawa T, Kishimoto Y, Takase Y. Hydrogen Permeation Measurements in the Spherical Tokamak QUEST and Its Numerical Modeling. Fusion Science and Technology 2011. [DOI: 10.13182/fst11-a12719] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- S. K. Sharma
- IGSES, Kyushu University, Kasuga, Fukuoka, 816-8580, Japan
| | - H. Zushi
- RIAM, Kyushu University, Kasuga, Fukuoka, 816-8580, Japan
| | - I. Takagi
- DNE, Graduate School of Engineering, Kyoto University, Japan
| | - Y. Hisano
- IGSES, Kyushu University, Kasuga, Fukuoka, 816-8580, Japan
| | - T. Shikama
- DNE, Graduate School of Engineering, Kyoto University, Japan
| | - S. Morita
- National Institute for Fusion Science, Toki, Japan
| | - T. Tanabe
- IGSES, Kyushu University, Kasuga, Fukuoka, 816-8580, Japan
| | - N. Yoshida
- RIAM, Kyushu University, Kasuga, Fukuoka, 816-8580, Japan
| | - M. Sakamoto
- RIAM, Kyushu University, Kasuga, Fukuoka, 816-8580, Japan
| | - Y. Higashizono
- RIAM, Kyushu University, Kasuga, Fukuoka, 816-8580, Japan
| | - K. Hanada
- RIAM, Kyushu University, Kasuga, Fukuoka, 816-8580, Japan
| | - M. Hasegawa
- RIAM, Kyushu University, Kasuga, Fukuoka, 816-8580, Japan
| | - O. Mitarai
- Kyushu Tokai University, 9-1-1 Toroku, Kumamoto 862-8, Japan
| | - K. Nakamura
- RIAM, Kyushu University, Kasuga, Fukuoka, 816-8580, Japan
| | - H. Idei
- RIAM, Kyushu University, Kasuga, Fukuoka, 816-8580, Japan
| | - K. N. Sato
- RIAM, Kyushu University, Kasuga, Fukuoka, 816-8580, Japan
| | - S. Kawasaki
- RIAM, Kyushu University, Kasuga, Fukuoka, 816-8580, Japan
| | - H. Nakashima
- RIAM, Kyushu University, Kasuga, Fukuoka, 816-8580, Japan
| | - A. Higashijima
- RIAM, Kyushu University, Kasuga, Fukuoka, 816-8580, Japan
| | - Y. Nakashima
- Plasma Research Center, University of Tsukuba, Japan
| | - N. Nishino
- DMSE, Graduate School of Engineering, Hiroshima University, Japan
| | - Y. Hatano
- Hydrogen Isotope Research Center, Toyama University, Toyama 930-855, Japan
| | - A. Sagara
- National Institute for Fusion Science, Toki, Japan
| | - Y. Nakamura
- National Institute for Fusion Science, Toki, Japan
| | - N. Ashikawa
- National Institute for Fusion Science, Toki, Japan
| | - T. Maekawa
- DNE, Graduate School of Engineering, Kyoto University, Japan
| | - Y. Kishimoto
- DNE, Graduate School of Engineering, Kyoto University, Japan
| | - Y. Takase
- Graduate School of Frontier Science, University of Tokyo, Ibaragi, Japan
| | | |
Collapse
|
42
|
Noguchi T, Irie H, Takase Y, Kawashima M, Ootsuka T, Nishihara M, Egashira Y, Nojiri J, Matsushima T, Kudo S. Hemodynamic studies of intracranial dural arteriovenous fistulas using arterial spin-labeling MR imaging. Interv Neuroradiol 2010; 16:409-19. [PMID: 21162771 DOI: 10.1177/159101991001600407] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2010] [Accepted: 09/26/2010] [Indexed: 11/17/2022] Open
Abstract
Arterial spin-labeling (ASL) magnetic resonance imaging (MRI) enables non-invasive acquisition of the brain perfusion information in cerebrovascular disease. We investigated hemodynamic changes in intracranial dural arteriovenous fistulas (DAVFs) using ASL-MRI. ASL-MRI by a Q2TIPS sequence on a 3.0-Tesla MRI was performed for three patients with Cognard's IIa+b type of DAVFs before and after treatment. Perfusion images obtained by ASL-MRI (ASL images) before treatment were visually compared with those by single-photon emission computed tomography images (SPECT images). Increasing rates of temporal changes of regional perfusion values in ASL images (ASL values) before and after treatment were also calculated. In all three patients, ASL images before treatment demonstrated high perfusion in regions around the shunting areas, where normal or low perfusion were detected on SPECT images; thus, ASL images might have demonstrated the abundant arterial shunting flow via the fistulas. On days eight to 20 after treatment, ASL values around the shunt areas remained the same or decreased, and those in the regions other than the shunt areas increased in all three patients. This might have been due to a combination of the following: a decrease in shunt flow volume, an amelioration of venous congestion, and a sustained an upward shift in the autoregulation of the brain perfusion pressure. All regional ASL values decreased on days 112 and 120 after treatment in two patients, which possibly reflects a reduction in the upward shift in autoregulation. ASL-MRI might be useful for identifying the hemodynamic behavior of DAVFs before and after treatment.
Collapse
Affiliation(s)
- T Noguchi
- Department of Radiology, Faculty of Medicine, Saga University; Nabeshima, Saga, Japan.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Watanabe K, Takase Y, Takahashi Y. P49. Cell reprogramming factors of neural crest cells. Differentiation 2010. [DOI: 10.1016/j.diff.2010.09.055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
44
|
Saito D, Ohata E, Murai H, Takase Y, Takahashi Y. P95. BMP-switching regulates lineage specification and migration of neural crest cells. Differentiation 2010. [DOI: 10.1016/j.diff.2010.09.101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
45
|
Kawashima M, Noguchi T, Takase Y, Nakahara Y, Matsushima T. Decrease in leptomeningeal ivy sign on fluid-attenuated inversion recovery images after cerebral revascularization in patients with Moyamoya disease. AJNR Am J Neuroradiol 2010; 31:1713-8. [PMID: 20466798 DOI: 10.3174/ajnr.a2124] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
BACKGROUND AND PURPOSE The "ivy" sign that is identified on FLAIR images in patients with Moyamoya disease is considered to be leptomeningeal collaterals. The aim of our study was to evaluate the correlation between postoperative decrease in ivy sign and cerebral hemodynamic status in the bypass-established hemisphere. MATERIALS AND METHODS Twenty-two patients with Moyamoya disease were enrolled. Postoperative changes in the ivy sign on FLAIR images were examined in each patient after bypass surgery. The correlation between postoperative changes in the ivy sign and hemodynamic status was examined in 10 patients by using SPECT. RESULTS Of the 22 preoperative ivy-positive patients, 21 showed decreased ivy signs on the operative side. Average intervals between the operation day and the date when the decreased or vanished ivy sign was first recognized were 157.6 days in patients who underwent direct bypass and 212.2 days in patients who underwent indirect bypass. A postoperative decrease in ivy signs was found to be significantly correlated with an improved hemodynamic status of the surgically treated hemisphere, resulting in a postoperative increase in regional vascular reserve and a decreased proportion of the misery perfusion area (P < .01). CONCLUSIONS Postoperative changes in the ivy sign can be used as a marker for identifying improved hemodynamics and also for testing the effectiveness of cerebral revascularization.
Collapse
Affiliation(s)
- M Kawashima
- Department of Neurosurgery, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, Japan.
| | | | | | | | | |
Collapse
|
46
|
Kawashima M, Noguchi T, Takase Y, Ootsuka T, Kido N, Matsushima T. Unilateral hemispheric proliferation of ivy sign on fluid-attenuated inversion recovery images in moyamoya disease correlates highly with ipsilateral hemispheric decrease of cerebrovascular reserve. AJNR Am J Neuroradiol 2009; 30:1709-16. [PMID: 19713323 DOI: 10.3174/ajnr.a1679] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
BACKGROUND AND PURPOSE An ivy sign is considered to represent diffuse leptomeningeal collaterals found on fluid-attenuated inversion recovery (FLAIR) images of patients with Moyamoya disease. We evaluated the correlation between unilateral ivy proliferation in a hemisphere and cerebrovascular hemodynamic status to learn the clinical significance of the ivy sign. MATERIALS AND METHODS A total of 35 patients with Moyamoya disease were included. Correlation between ivy dominance on FLAIR images and hemodynamic status with use of iodine 123 N-isopropyl-p-iodoamphetamine ((123)I-IMP) single-photon emission CT (SPECT) was evaluated. RESULTS Distributional differences of ivy signs between both hemispheres were observed in 22 (64.7%) of 34 patients with a positive ivy sign, all of whom showed decreased vascular reserve/reactivity in the ivy-dominant hemisphere (IDH). The proportion of the stage II (misery perfusion) area to IDH was higher than that in the ivy less-dominant hemisphere (ILDH) in the quantitative analysis. The mean vascular reserve was lower in IDH than ILDH. There were 15 of 22 patients who had bypass surgery on IDH because of transient ischemic attack from ischemia of IDH. Patients with symmetric ivy distributions showed a variety of hemodynamic status. MR angiography (MRA) stage of IDH (2.95 +/- 0.39) was higher compared with ILDH (2.60 +/- 0.50; P < .05). Regional arteriocapillary circulation time ratio in IDH was longer compared with ILDH (P < .05). Ivy proliferation decreased in 10 (55.6%) of 18 patients who underwent bypass surgery during the follow-up period. CONCLUSIONS Unilateral hemispheric ivy proliferation correlated highly with the existence of an ipsilateral decreased vascular reserve associated with the development of leptomeningeal collaterals in patients with Moyamoya disease.
Collapse
Affiliation(s)
- M Kawashima
- Department of Neurosurgery, Faculty of Medicine, Saga University, Saga, Japan.
| | | | | | | | | | | |
Collapse
|
47
|
Uchino A, Egashira R, Nomiyama K, Takase Y, Kudo S. Visualization of the Superior Ophthalmic Veins by 3 Tesla 3D-TOF-MR Angiography. Neuroradiol J 2008; 21:619-22. [PMID: 24257001 DOI: 10.1177/197140090802100502] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2008] [Accepted: 08/09/2008] [Indexed: 11/17/2022] Open
Abstract
The superior ophthalmic veins (SOVs) are sometimes visualized on three-dimensional time-of-flight magnetic resonance (3D-TOF-MR) angiograms obtained with a 3 Tesla system. The purpose of this retrospective study was to determine the incidence of visualization of normal SOVs on 3D-TOF-MR angiograms, and their characteristic features. We reviewed 3D-TOF-MR angiograms of 345 consecutive patients obtained with a 3 Tesla MR device. Patients comprised 170 males and 175 females, aged five to 93 years. Most of the patients had, or were thought to have, cerebrovascular disease. The SOV was visualized in 13 of the 345 patients (3.8%). The visualized SOV was on the left side in seven of the 13, and on the right side in two. Both the right and left SOVs were visualized in four patients. The left SOV was more clearly visualized in two of these patients, whereas the SOVs were equally visible on both sides in the other two. There was a female predominance (M:F = 1:12) but no relation between age and visualization of SOVs. None of the visualized SOVs were dilated, and no dilated cavernous sinus was seen. The facial veins and angular veins were also visualized, continuing to the SOVs, suggesting rapid retrograde flow in the facial veins. SOVs are sometimes visualized on 3D-TOF-MR angiograms. This phenomenon should not be misdiagnosed as an asymptomatic dural carotid-cavernous fistula.
Collapse
Affiliation(s)
- A Uchino
- Department of Diagnostic Radiology, Saitama Medical University, International Medical Center; Saitama, Japan -
| | | | | | | | | |
Collapse
|
48
|
|
49
|
|
50
|
Tojo H, Ejiri A, Gryaznevich MP, Takase Y, Adachi Y. Poloidal mode analysis of magnetic probe data in a spherical tokamak configuration. Rev Sci Instrum 2008; 79:10F120. [PMID: 19044604 DOI: 10.1063/1.2965014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
A method to determine the poloidal mode number m in a spherical tokamak based on magnetic probe data was developed. Perturbed magnetic fields at Mirnov coils are calculated for distributed helical filamentary currents on rational surfaces assuming the maximum current amplitude, m and n (toroidal mode number), and the toroidal location of the filaments. These free parameters were determined from the best fit to the measured signals. The residual error was reduced by a factor of 2 by introducing helical filaments instead of toroidal filaments. Using this method, m/n=2/1 and 3/2 modes were identified in Mega-Ampere Spherical Tokamak discharges, and the time evolution of the tearing modes was derived.
Collapse
Affiliation(s)
- H Tojo
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan.
| | | | | | | | | |
Collapse
|